Marshall Wace’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $312K | Sell |
142,008
-100,368
| -41% | -$221K | ﹤0.01% | 2178 |
|
2025
Q1 | $281K | Buy |
+242,376
| New | +$281K | ﹤0.01% | 2171 |
|
2024
Q4 | – | Sell |
-63,759
| Closed | -$217K | – | 2487 |
|
2024
Q3 | $217K | Sell |
63,759
-385,394
| -86% | -$1.31M | ﹤0.01% | 2107 |
|
2024
Q2 | $2.1M | Sell |
449,153
-342,167
| -43% | -$1.6M | ﹤0.01% | 1231 |
|
2024
Q1 | $5.87M | Sell |
791,320
-319,882
| -29% | -$2.37M | 0.01% | 830 |
|
2023
Q4 | $11.3M | Sell |
1,111,202
-1,083,604
| -49% | -$11M | 0.02% | 556 |
|
2023
Q3 | $17.1M | Sell |
2,194,806
-643,511
| -23% | -$5.02M | 0.03% | 446 |
|
2023
Q2 | $23.4M | Buy |
+2,838,317
| New | +$23.4M | 0.05% | 379 |
|
2023
Q1 | – | Sell |
-23,867
| Closed | -$212K | – | 2253 |
|
2022
Q4 | $212K | Buy |
+23,867
| New | +$212K | ﹤0.01% | 2097 |
|
2022
Q2 | – | Sell |
-17,725
| Closed | -$337K | – | 2800 |
|
2022
Q1 | $337K | Sell |
17,725
-368,902
| -95% | -$7.01M | ﹤0.01% | 2238 |
|
2021
Q4 | $10.3M | Buy |
+386,627
| New | +$10.3M | 0.02% | 780 |
|
2019
Q1 | – | Sell |
-17,905
| Closed | -$408K | – | 1788 |
|
2018
Q4 | $408K | Buy |
+17,905
| New | +$408K | ﹤0.01% | 1162 |
|